SRAX Inc. (NASDAQ: SRAX) Uncovers Millennials’ Love for

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
268
SRAX Inc. (NASDAQ: SRAX) Uncovers Millennials’ Love for Experience-Based Gifts

- SRAX discovers valuable new trend in consumer behavior, a move toward purchasing experiences for Valentine’s Day
- BIGtoken has grown to more than 16.5 million participants who are 100% opted-in
- Consumers may be leaving social media platforms, but they are choosing BIGtoken, where both consumers and marketers benefit

SRAX Inc. (NASDAQ: SRAX) is building the largest, most valuable opted-in data set in the world while also providing marketers and consumers tools to unlock the value of data. A digital marketing and consumer data management technology company, SRAX recently announced that its BIGresearch efforts uncovered a new trend in consumer behaviors and opinions this Valentine’s Day (http://nnw.fm/SQrj1). The company continues to leverage its increasingly valuable opted-in database of consumer information to glean marketable insights into societal trends.

The BIGresearch announcement explained that SRAX compiled research from more than 53,000 individual Americans who opted in to the study. Beginning in January 2020, BIGtoken users were asked what they planned to give their significant others this year for Valentine’s Day. Millennials, who make up the majority of those who celebrate this holiday, responded that they planned to give experiences.

“Changing values and opinions in consumers greatly affect their consumption patterns, and it’s up to marketers to stay ahead of the curve,” SRAX COO Kristoffer Nelson stated in a news release. “We are thrilled to share results from our latest BIGresearch report, highlighting Valentine’s Day, a holiday that’s seen new movements over the past couple decades, like the rise of Galentine’s Day (ladies celebrating ladies), and more people shopping and celebrating anti-valentine’s day.”

SRAX provided the same high-quality data found in this report to advertisers, for a premium, prior to the February holiday, allowing advertisers to better target consumers who had indicated an interest in their specific campaigns. The sample data provided a look at the value marketers and content owners receive when they purchase access to data gathered through BIGtoken.

BIGtoken is the first consumer-managed data marketplace that places control of personal data in the hands of the consumer. Through BIGtoken, individuals can own and earn from their data, making it an optimal platform for conducting accurate primary research. The 100% opted-in audience has rapidly grown, currently numbering more than 16.5 million participating consumers.

Consumers benefit from controlling their personal data, something the average customer is only just beginning to understand the true value of. SRAX is making this control as simple as downloading an app, answering a few questions and receiving payment. Consumers are discovering brands they love and are willing to be loyal to because they have control over opting into targeted messages rather than having to sort through the noise coming from innumerable businesses, many of whom they would never become customers of regardless of the amount of marketing dollars thrown at them.

Every person is a commodity with potential to generate significant revenue, yet in the past, consumers have never seen a penny of that revenue. SRAX believes that digital data should not be traded in without compensation. BIGtoken, a secure platform, empowers consumers to own and monetize their digital information. The platform is available for download on the App Store and Google Play and has grown to more than 16.5 million participating consumers worldwide, each of whom can log in and check their earnings at their convenience. The future of data is in the hands of consumers, and SRAX is making the transition valuable for all.

Traditionally social media has provided a wealth of information for marketers, but that information is often inaccurate. In addition, consumers have become increasingly aware of the value of their information and have rejected typical data mining efforts. Twitter has increased efforts to delete suspicious accounts (http://nnw.fm/1O2mM) while Facebook refused to revise its tracking practices, consequently losing 15 million users since 2017 (http://nnw.fm/QxRp4). The Daily Mail reported that a third of millennials have permanently given up social media (http://nnw.fm/EOL1b).

Meanwhile, SRAX’s BIGtoken platform is only growing worldwide. Millennials chose to share their Valentine’s Day plans knowing that their data was safe with SRAX, that it would only be accessible to companies they had expressed interest in, and that they, the consumers, would directly receive monetization for sharing. Thanks to SRAX, the power of personal data is in the hands of the consumer – right where it should be.

For more information, visit the company’s website at www.SRAX.com

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

SRAX Inc. (SRAX) Stock Research Links

SRAX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Black Friday Doubt Grows: Just 54% Trust Real Deals

Updated Category News Views 93

Do Shoppers Believe in Black Friday Anymore? You'd think by now, retailers would have cracked the code on building trust with their customers. But guess what? A fresh survey from Boston Consulting Group reveals only 54% of consumers buy the whole Black Friday discount story. That's barely more than flipping a coin. Promotion Fatigue: The Trust Buster Funny thing,...

Continue Reading
CStone, Kimia Collaboration Targets Solid Tumor Survival

Updated Category News Views 106

Biotech Giants CStone and Kimia Unite Forces In the heart of China's biotechnology scene, the latest collaboration news to hit the wires is CStone Pharmaceuticals shaking hands with Kimia Therapeutics. Now, don't go tossing this aside as another run-of-the-mill partnership announcement. CStone's HKEX: 2616 ticker has got its eyes locked on an ambitious dance with Kimia,...

Continue Reading
Samsung Biologics Hits 'Negligible' ESG Risk Milestone

Updated Category News Views 60

Samsung Biologics Achieves a Low-Risk Triumph You gotta hand it to Samsung Biologics for hitting a 'Negligible Risk' rating. Their latest score? A cool 9.0. That’s like walking into the pharmaceuticals room and getting a standing ovation. It's no small feat—climbing up from a 'Low Risk' rating to the top tier in Morningstar Sustainalytics' playbook. For us spectating...

Continue Reading
Emergency Surgery Verification Lowers Death Rates: Study

Updated Category News Views 37

Diving into Emergency General Surgery Verification How often do you hear a hospital accreditation making a real difference? The latest report in JAMA Surgery suggests it’s more than just a plaque on the wall for some. We're talking about the American College of Surgeons (ACS) Emergency General Surgery Verification program, which links directly to better patient...

Continue Reading
Stellus Capital Set to Unveil Q3 Results: Key Details

Updated Category News Views 92

Stellus Capital's Upcoming Financial Reveal: Stakes and Details November's not just bringing the cold breezes, folks; it's also ushering in the much-anticipated financial digits of Stellus Capital Investment Corporation's third quarter of 2026. Mark your calendars for November 9, after the stock market wraps up, when Stellus will drop its operational performance stats for...

Continue Reading
Life with PAH: A Journey of Awareness and Hope

Updated Category News Views 224

Unearthing the Hidden Struggle of PAH The American Lung Association (ALA) is getting loud about a quiet killer—pulmonary arterial hypertension (PAH) is in their spotlight this month, and it's about time. Documenting the horror stories of some 500 to 1,000 new PAH diagnoses each year in the U.S., the ALA is peeling back the blinds on a condition that's too often...

Continue Reading
KFC Teams with Marvel for Record-Breaking Menu Launch

Updated Category News Views 124

Movie Magic on the Menu When was the last time a bucket of fried chicken sent such ripple effects through pop culture? KFC's decision to sling Doctor Doom-inspired dishes across 100 countries smells like genius business mixed with a dash of the absurd. Just imagine: an empire of battered birds aligning with Marvel's latest cinematic heavy hitter, "Avengers: Doomsday." Now...

Continue Reading
AppLovin Faces Lawsuit: Investor Unrest Unfolds

Updated Category News Views 160

Shaky Ground Beneath AppLovin's Feet Ah, the sweet smell of litigation in the tech space—it’s like déjà vu for seasoned market folks. Here we have AppLovin, nestled comfortably in San Francisco, now eying a saucy class-action lawsuit. We're looking at shareholders taking a firm stance against some arguably misleading claims. We're talking big deals with allegations...

Continue Reading
Singtel, Ericsson Push 6G Healthcare to the Forefront

Updated Category News Views 83

Breaking Ground in Healthcare Tech Ah, what’s cooking in Singapore? On a day like today, when the tech giants Singtel and Ericsson get chummy with National University Health System (NUHS), we're looking at the kind of healthcare advancements that read like science fiction. They’ve signed an MOU to launch the National University XG AI Centre (NXAC) – a mouthful,...

Continue Reading
Lakefront Living: Steuben County's Twin Tales

Updated Category News Views 22

Here’s how it is: choosing a lakefront home in Steuben County, Indiana, ain't just about picking a place with a killer view. It’s like buying a lifestyle package and you’d better know what you’re getting. An article by Tony Isa, the go-to real estate guru in these parts, puts the spotlight on Lake James and Clear Lake—but what matters is how each might wrangle...

Continue Reading

Top 5 Most Recently Viewed Articles

Recent Insider Trading Insights on Teva Pharmaceutical Stock

Updated Category News Views 155

Recent Insider Trading at Teva Pharmaceutical Industries A notable insider transaction occurred recently, with Amir Weiss, the Chief Accounting Officer at Teva Pharmaceutical Industries Ltd (NYSE: TEVA), unloading shares worth $300,564 as reported by a recent SEC filing. Details of the Transaction According to the Form 4 filing submitted to the U.S. Securities and...

Continue Reading
TIER IV and Newmo Join Forces for Innovative Robotaxi Services

Updated Category News Views 266

Transforming Mobility with Robotaxi Services TIER IV, renowned for developing the first open-source software for autonomous driving, has teamed up with mobility startup Newmo to revolutionize transportation services. This partnership marks a significant step toward the commercialization of robotaxi services, offering solutions tailored for local communities. Your Solution...

Continue Reading
Investors of Wolfspeed Inc. Face Deadline for Class Action Claims

Updated Category News Views 262

Investors Urged to Take Action After Stock Price Drop Recent developments surrounding Wolfspeed, Inc. have raised significant concerns among investors, especially following the staggering drop in the company's stock price. Those who invested in Wolfspeed, often identified by its ticker WOLF, may now find themselves questioning their portfolio decisions. Amidst this...

Continue Reading
Team Falcons Triumphs at Esports World Cup 2025 Championship

Updated Category News Views 261

Team Falcons' Incredible Journey to Victory The culmination of the Esports World Cup 2025 showcased an exhilarating journey for Team Falcons, who emerged as the dominant force in this prestigious multi-title esports tournament. Over seven weeks, the tournament attracted a staggering 750 million viewers worldwide and recorded 350 million hours of online watch time. These...

Continue Reading
GENFIT's 2024 Registration Document and Annual Report Release

Updated Category News Views 224

GENFIT Files 2024 Universal Registration Document Lille, France - GENFIT (Nasdaq and Euronext: GNFT), a pioneering biopharmaceutical firm dedicated to the welfare of patients suffering from rare and life-threatening liver conditions, has achieved a significant milestone by filing its 2024 Universal Registration Document alongside its Annual Report on Form 20-F with...

Continue Reading